• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Dietary Supplements & FDA Use of Adverse Event Reports

Dietary Supplements & FDA Use of Adverse Event Reports

9781628080230
314.94 zł
283.44 zł Save 31.50 zł Tax included
Lowest price within 30 days before promotion: 283.44 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Manufacturers, packers, and distributors of dietary supplements in the United States are required to report information about serious adverse effects associated with the use of these supplements to the Food and Drug Administration (FDA). The FDA carefully considers all the available safety information submitted to the agency before a product is approved. However, unexpected and sometimes serious safety problems can emerge once a product goes to market and is used by millions of people. As a result, post-market safety monitoring, that is, analysing information on products once they go to market, is a critical part of the FDAs responsibilities. The public provides an important source of such safety information. Health care facilities, practitioners, and patients submit reports to the FDA and to manufacturers on advise events, medical errors, and product quality problems observed during the use of a product. This book examines the number of adverse event reports the FDA has received since 2008; their source and types of products identified, and the actions the FDA has taken to ensure that firms are complying with adverse event report requirements.
Product Details
74263
9781628080230
9781628080230

Data sheet

Publication date
2013
Issue number
1
Cover
paperback
Pages count
71
Dimensions (mm)
155.00 x 230.00
Weight (g)
140
  • Preface; Dietary Supplements:: FDA May Have Opportunities to Expand Its Use of Reported Health Problems to Oversee Products; For Industry:: Dietary Supplements -- Reporting an Adverse Event At a Glance; Q&A on Dietary Supplements; The Publics Stake in Adverse Event Reporting; Index.
Comments (0)